EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

New evidence in the management of CMV infection: impact on prophylaxis and treatment

Jesús Fortún iD

Revista Española de Quimioterapia · 2025

DOI: 10.37201/req/s01.12.2025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Revista Española de Quimioterapia, 2025. Verfasst von Jesús Fortún. Beteiligte Einrichtung: Servicio de Enfermedades Infecciosas, Hospital Ramón y Cajal, CIBERINFEC. Universidad de Alcalá, Madrid, Spain. fortunabete@gmail.com. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Antiviral Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytomegalovirus (CMV) infection is a leading cause of morbidity and mortality among immunocompromised individuals, especially hematopoietic stem cell transplant and solid organ transplant recipients. In recent years, significant advances have transformed the approach to CMV prevention and therapy. This manuscript explores key evidence regarding antiviral prophylaxis, treatment strategies, resistance mechanisms, and the potential of immune-guided monitoring in transplant settings. The role of novel agents such as letermovir and maribavir is highlighted. These findings support personalized strategies that balance efficacy, toxicity, and resistance in managing CMV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsAntiviral AgentsHumansImmunocompromised HostDrug Resistance, ViralCytomegalovirusHematopoietic Stem Cell TransplantationAcetatesQuinazolines

Stichwörter der Autor:innen

CMVLetermovirMaribavirTransplantation

Substanzen

Antiviral AgentsletermovirAcetatesQuinazolines

Autor:innen und Institutionen

  • Servicio de Enfermedades Infecciosas, Hospital Ramón y Cajal, CIBERINFEC. Universidad de Alcalá, Madrid, Spain. fortunabete@gmail.com.

ORCID-Profile: Jesús Fortún

Zitieren

APA

Fortún, J. (2025). New evidence in the management of CMV infection: impact on prophylaxis and treatment. Revista Española de Quimioterapia. https://doi.org/10.37201/req/s01.12.2025

Vancouver

Fortún J. New evidence in the management of CMV infection: impact on prophylaxis and treatment. Revista Española de Quimioterapia. 2025. doi:10.37201/req/s01.12.2025

BibTeX
@article{Fortn2025,
  author = {Fortún, Jesús},
  title = {New evidence in the management of CMV infection: impact on prophylaxis and treatment},
  journal = {Revista Española de Quimioterapia},
  year = {2025},
  doi = {10.37201/req/s01.12.2025}
}
Kostenlos starten →